News Daily News Evidence Does Not Support Widespread Preparticipation ECG Screening in Young Athletes Michael O'Riordan April 22, 2016
News Conference News ACC 2016 Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon Michael O'Riordan April 06, 2016
Presentation ECHO 2016 Hypertrophic Cardiomyopathy: Diagnosis and Management Presenter: Gerard P. Aurigemma March 21, 2016
Presentation TCT 2015 Heart Block at Day 3 After Alcohol Septal Ablation. What to Do Now? Presenter: Dominique Himbert, Paul Sorajja, John C. Messenger October 15, 2015
Presentation TCT 2015 Alcohol Septal Ablation: My Worst Complication (and What I Wish I Did Differently) Presenter: Dominique Himbert, Paul Sorajja, Carey D. Kimmelstiel October 15, 2015
Presentation TCT 2015 Who to Restrict for Athletic Participation Presenter: Dominique Himbert, Paul Sorajja October 15, 2015
Presentation TCT 2015 Debate 3: Which Age Group Should Be Referred for Alcohol Septal Ablation? The Procedure Should Be Offered to Elderly Patients Only! Presenter: Srihari S. Naidu, Paul Sorajja, John S. Douglas Jr October 15, 2015
Presentation TCT 2015 Debate 3: Which Age Group Should Be Referred for Alcohol Septal Ablation? The Procedure Is Equally Effective at All Ages! Presenter: Srihari S. Naidu, Paul Sorajja, George S. Hanzel October 15, 2015
Presentation TCT 2015 Alcohol Septal Ablation Is the Choice for Most Cases! Presenter: Srihari S. Naidu, Paul Sorajja October 15, 2015
Presentation TCT 2015 Debate 1: Does Alcohol Septal Ablation Increase the Risk for Sudden Cardiac Death? No, It Does Not! Presenter: Srihari S. Naidu, Paul Sorajja October 15, 2015
Presentation TCT 2015 Debate 1: Does Alcohol Septal Ablation Increase the Risk for Sudden Cardiac Death? Yes, Definitely! Presenter: Srihari S. Naidu, Paul Sorajja, Valerian Fernandes October 15, 2015
Presentation TCT 2015 HCM Ablation Step-by-Step Approach, Complications, and Long-term Outcomes Presenter: John S. Douglas Jr, Sherif F. Nagueh, Valerian Fernandes October 15, 2015
Presentation TCT 2015 CTA for Procedure Planning Presenter: John S. Douglas Jr, Sherif F. Nagueh, Jorge Gaspar October 15, 2015
Presentation TCT 2015 Indications for Septal Reduction Therapy Presenter: John S. Douglas Jr, Sherif F. Nagueh October 15, 2015
Presentation TCT 2015 Medical Management: Agents and Effectiveness Presenter: John S. Douglas Jr, Sherif F. Nagueh, Mark V. Sherrid October 15, 2015
Presentation TCT 2015 Pathophysiology and Natural History Presenter: John S. Douglas Jr, Sherif F. Nagueh, Mark V. Sherrid October 15, 2015
Presentation TCT 2015 Severe Septal Bulge (± Hypertrophic Cardiomyopathy) and TAVR: Thoughtful Commentary on the Case Presenter: D. Craig Miller, Alec S. Vahanian, Jan Kovac October 12, 2015
Presentation TCT 2015 Severe Septal Bulge (± Hypertrophic Cardiomyopathy) and TAVR: Case Presentation Presenter: D. Craig Miller, Alec S. Vahanian, Mayra Guerrero October 12, 2015
News Industry News MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy October 07, 2015